Page 5 - Nasdaq Fdmt News Today

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the nine research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 2,840,000 shares, a drop of 10.1% from the April 15th total of 3,160,000 shares. Based on an average trading volume of 510,400 shares, the days-to-cover ratio […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) gapped down prior to trading on Tuesday . The stock had previously closed at $17.82, but opened at $17.23. 4D Molecular Therapeutics shares last traded at $17.51, with a volume of 51,817 shares trading hands. Analysts Set New Price Targets FDMT has been the subject of a […]

Denali Advisors LLC purchased a new position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) in the 4th quarter, HoldingsChannel reports. The firm purchased 2,000 shares of the company’s stock, valued at approximately $44,000. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Belpointe Asset Management […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) – Stock analysts at SVB Leerink upped their Q2 2023 earnings per share estimates for shares of 4D Molecular Therapeutics in a report issued on Wednesday, May 10th. SVB Leerink analyst M. Foroohar now expects that the company will earn ($0.61) per share for the quarter, up […]

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) traded down 11.7% during mid-day trading on Thursday . The stock traded as low as $16.65 and last traded at $16.80. 88,492 shares changed hands during trading, a decline of 79% from the average session volume of 418,826 shares. The stock had previously closed at […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $20.57, but opened at $16.33. 4D Molecular Therapeutics shares last traded at $15.71, with a volume of 1,208,423 shares trading hands. Analyst Ratings Changes A number of equities research analysts have […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) Director Jacob Chacko sold 5,000 shares of the business’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $20.05, for a total transaction of $100,250.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) insider Scott Bizily sold 3,750 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $20.00, for a total transaction of $75,000.00. Following the completion of the sale, the insider now owns 2,109 shares in the […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 3,120,000 shares, an increase of 19.5% from the March 15th total of 2,610,000 shares. Based on an average daily trading volume, of 355,900 […]